Literature DB >> 11247714

Ticks and tickborne bacterial diseases in humans: an emerging infectious threat.

P Parola1, D Raoult.   

Abstract

Ticks are currently considered to be second only to mosquitoes as vectors of human infectious diseases in the world. Each tick species has preferred environmental conditions and biotopes that determine the geographic distribution of the ticks and, consequently, the risk areas for tickborne diseases. This is particularly the case when ticks are vectors and reservoirs of the pathogens. Since the identification of Borrelia burgdorferi as the agent of Lyme disease in 1982, 15 ixodid-borne bacterial pathogens have been described throughout the world, including 8 rickettsiae, 3 ehrlichiae, and 4 species of the Borrelia burgdorferi complex. This article reviews and illustrate various aspects of the biology of ticks and the tickborne bacterial diseases (rickettsioses, ehrlichioses, Lyme disease, relapsing fever borrelioses, tularemia, Q fever), particularly those regarded as emerging diseases. Methods are described for the detection and isolation of bacteria from ticks and advice is given on how tick bites may be prevented and how clinicians should deal with patients who have been bitten by ticks.

Entities:  

Mesh:

Year:  2001        PMID: 11247714     DOI: 10.1086/319347

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  285 in total

1.  Serological evidence of rickettsial infections in Delhi.

Authors:  Veena Mittal; Naveen Gupta; Dipesh Bhattacharya; Kaushal Kumar; R L Ichhpujani; Sharda Singh; Mala Chhabra; U V S Rana
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

2.  Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis.

Authors:  Jennifer C McClure; Michelle L Crothers; John J Schaefer; Patrick D Stanley; Glen R Needham; S A Ewing; Roger W Stich
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

3.  Antibiotics for Travelers: What's Good and What's Not.

Authors:  Kathryn N. Suh; Jay S. Keystone
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

4.  Rickettsia aeschlimannii in Hyalomma ticks from Corsica.

Authors:  K Matsumoto; P Parola; P Brouqui; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-10       Impact factor: 3.267

Review 5.  Tick saliva in anti-tick immunity and pathogen transmission.

Authors:  L Kovár
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

Review 6.  Emerging horizons for tick-borne pathogens: from the 'one pathogen-one disease' vision to the pathobiome paradigm.

Authors:  Muriel Vayssier-Taussat; Maria Kazimirova; Zdenek Hubalek; Sándor Hornok; Robert Farkas; Jean-François Cosson; Sarah Bonnet; Gwenaël Vourch; Patrick Gasqui; Andrei Daniel Mihalca; Olivier Plantard; Cornelia Silaghi; Sally Cutler; Annapaola Rizzoli
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

7.  Proteome of Rhipicephalus sanguineus tick saliva induced by the secretagogues pilocarpine and dopamine.

Authors:  C J Oliveira; E Anatriello; I K de Miranda-Santos; I M Francischetti; A Sá-Nunes; B R Ferreira; J M C Ribeiro
Journal:  Ticks Tick Borne Dis       Date:  2013-09-09       Impact factor: 3.744

8.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of tick vectors.

Authors:  Amina Yssouf; Christophe Flaudrops; Rezak Drali; Tahar Kernif; Cristina Socolovschi; Jean-Michel Berenger; Didier Raoult; Philippe Parola
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

9.  Elemol and amyris oil repel the ticks Ixodes scapularis and Amblyomma americanum (Acari: Ixodidae) in laboratory bioassays.

Authors:  J F Carroll; G Paluch; J Coats; M Kramer
Journal:  Exp Appl Acarol       Date:  2009-12-18       Impact factor: 2.132

10.  Increased prevalence of Rickettsia aeschlimannii in Castilla y León, Spain.

Authors:  P Fernández-Soto; V Díaz Martín; R Pérez-Sánchez; A Encinas-Grandes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.